Membrane type-1 matrix metalloproteinase is induced following cyclic compression of in vitro grown bovine chondrocytes  J.N.A. De Croos, Ph.D., B. Jang,

Slides:



Advertisements
Similar presentations
Pro-inflammatory stimulation of meniscus cells increases production of matrix metalloproteinases and additional catabolic factors involved in osteoarthritis.
Advertisements

Figure 3. Activation of Wild-Type and Point-Mutated MMP-9 Promoter Constructs by IL-1β A, Schematic representation of the different 1.3-kb MMP-9-luciferase.
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Mira Park, Ph. D. , Dae-Shik Suh, M. D. , Kangseok Lee, Ph. D
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities 
W. L. Parker, M. D. , Ph. D. , K. W. Finnson, Ph. D. , H. Soe-Lin, B
Xibin Wang, Ph. D. , Paul A. Manner, M. D. , Alan Horner, Ph. D
P38γ mitogen-activated protein kinase suppresses chondrocyte production of MMP-13 in response to catabolic stimulation  D.L. Long, R.F. Loeser  Osteoarthritis.
Histone deacetylase inhibitors suppress mechanical stress-induced expression of RUNX-2 and ADAMTS-5 through the inhibition of the MAPK signaling pathway.
Hyaluronan oligosaccharide treatment of chondrocytes stimulates expression of both HAS-2 and MMP-3, but by different signaling pathways  I. Schmitz, W.
M. -H. Moon, J. -K. Jeong, Y. -J. Lee, J. -W. Seol, C. J. Jackson, S
N. Zhong, J. Sun, Z. Min, W. Zhao, R. Zhang, W. Wang, J. Tian, L
Impaired glycolytic metabolism causes chondrocyte hypertrophy-like changes via promotion of phospho-Smad1/5/8 translocation into nucleus  T. Nishida,
Strain-induced mechanotransduction through primary cilia, extracellular ATP, purinergic calcium signaling, and ERK1/2 transactivates CITED2 and downregulates.
Endoglin differentially regulates TGF-β-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and.
Inhibition of cyclooxygenase 2 expression by diallyl sulfide on joint inflammation induced by urate crystal and IL-1β  H.-S. Lee, M.D., Ph.D., C.-H. Lee,
Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-α but not IL-1β treatment at a post-transcriptional level in bovine cartilage.
NF-κBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1β-induced and TNF-α-induced chondrocytes  Dr C. Lianxu, Ph.D.,
Stress-induced signaling pathways in hyalin chondrocytes: inhibition by Avocado– Soybean Unsaponifiables (ASU)  O. Gabay, B.Sc., Ph.D. fellow, M. Gosset,
L. Raymond, S. Eck, E. Hays, I. Tomek, M. D. , S. Kantor, M. D. , M
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Histone deacetylase inhibitors suppress interleukin-1β-induced nitric oxide and prostaglandin E2 production in human chondrocytes  N. Chabane, M.Sc.,
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing.
C. Jacques, Ph. D. , A. D. Recklies, Ph. D. , A. Levy, F. Berenbaum, M
Human osteoarthritic chondrocytes are impaired in matrix metalloproteinase-13 inhibition by IFN-γ due to reduced IFN-γ receptor levels  R. Ahmad, M. El.
IFN-γ Upregulates Expression of the Mouse Complement C1rA Gene in Keratinocytes via IFN-Regulatory Factor-1  Sung June Byun, Ik-Soo Jeon, Hyangkyu Lee,
The interferon regulatory factor ICSBP/IRF-8 in combination with PU
Pro-inflammatory stimulation of meniscus cells increases production of matrix metalloproteinases and additional catabolic factors involved in osteoarthritis.
Istvan Arany, Judit K. Megyesi, Jane E.B. Reusch, Robert L. Safirstein 
Volume 54, Issue 1, Pages (July 1998)
Α-MSH inhibits TNF-α-induced matrix metalloproteinase-13 expression by modulating p38 kinase and nuclear factor κB signaling in human chondrosarcoma HTB-94.
Rose-Anne Romano, Barbara Birkaya, Satrajit Sinha 
J.A. Roman-Blas, M.D., D.G. Stokes, Ph.D., S.A. Jimenez, M.D. 
Comparative analysis with collagen type II distinguishes cartilage oligomeric matrix protein as a primary TGFβ-responsive gene  H. Li, D.R. Haudenschild,
Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation  A.
Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration  Brenda B. Hoffman, Kumar Sharma,
Andreea M. Bujor, Jaspreet Pannu, Shizhong Bu, Edwin A. Smith, Robin C
Roles for the interleukin-4 receptor and associated JAK/STAT proteins in human articular chondrocyte mechanotransduction  S.J. Millward-Sadler, Ph.D.,
Expression and regulation of Toll-like receptor 2 by IL-1β and fibronectin fragments in human articular chondrocytes  S.-L. Su, M.S., C.-D. Tsai, Ph.D.,
A. Woods, Ph. D. , D. Pala, M. Sc. , L. Kennedy, M. Sc. , S. McLean, B
Evidence for two distinct pathways in TNFα-induced membrane and soluble forms of ICAM-1 in human osteoblast-like cells isolated from osteoarthritic patients 
DIO2 modifies inflammatory responses in chondrocytes
Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes  A.W.M. Cheng,
Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes 
Enhancing and maintaining chondrogenesis of synovial fibroblasts by cartilage extracellular matrix protein matrilins  M. Pei, M.D., Ph.D., J. Luo, M.D.,
Dr J. Deschner, D. M. D. , Ph. D. , Dr B. Rath-Deschner, D. M. D. , Ph
Volume 62, Issue 3, Pages (September 2002)
Mitogen-activated protein kinase-activated protein kinase 2 (MK2) modulates key biological pathways associated with OA disease pathology  S.W. Jones,
Z. Lin, M. B. , N. J. Pavlos, B. Sc. (Hons. ), Ph. D. , M. A. Cake, B
Stratifin-Induced Matrix Metalloproteinase-1 in Fibroblast Is Mediated by c-fos and p38 Mitogen-Activated Protein Kinase Activation  Eugene Lam, Runhangiz.
Transcriptional Regulation of ATP2C1 Gene by Sp1 and YY1 and Reduced Function of its Promoter in Hailey–Hailey Disease Keratinocytes  Hiroshi Kawada,
Histamine Enhances the Production of Granulocyte-Macrophage Colony-Stimulating Factor via Protein Kinase Cα and Extracellular Signal-Regulated Kinase.
Ketoconazole Suppresses Prostaglandin E2-Induced Cyclooxygenase-2 Expression in Human Epidermoid Carcinoma A-431 Cells  Naoko Kanda, Dr., Shinichi Watanabe 
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
Activation by IL-1 of bovine articular chondrocytes in culture within a 3D collagen-based scaffold. An in vitro model to address the effect of compounds.
Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes 
Regulation of mechanical stress-induced MMP-13 and ADAMTS-5 expression by RUNX-2 transcriptional factor in SW1353 chondrocyte-like cells  T. Tetsunaga,
Matrix metalloproteinase-13 influences ERK signalling in articular rabbit chondrocytes  L.J. Raggatt, Ph.D., S.C. Jefcoat, M.S., I. Choudhury, Ph.D., S.
Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation  Y. Akasaki, M.D., S. Matsuda,
Comparative effects of IL-1β and hydrogen peroxide (H2O2) on catabolic and anabolic gene expression in juvenile bovine chondrocytes  G. Martin, Ph.D.,
Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage  P. Patwari, G. Gao, J.H.
A single application of cyclic loading can accelerate matrix deposition and enhance the properties of tissue-engineered cartilage  Dr S.D. Waldman, Ph.D.,
Volume 122, Issue 1, Pages (January 2002)
Volume 67, Issue 6, Pages (June 2005)
Chondrogenic progenitor cells promote vascular endothelial growth factor expression through stromal-derived factor-1  S. Wang, C. Zhou, H. Zheng, Z. Zhang,
1α,25-Dihydroxyvitamin D3 Stimulates Activator Protein 1 DNA-Binding Activity by a Phosphatidylinositol 3-Kinase/Ras/MEK/Extracellular Signal Regulated.
Volume 70, Issue 5, Pages (September 2006)
John M. Lamar, Vandana Iyer, C. Michael DiPersio 
Volume 72, Issue 2, Pages (July 2007)
IGF-1 regulation of type II collagen and MMP-13 expression in rat endplate chondrocytes via distinct signaling pathways  M. Zhang, Ph.D., Q. Zhou, M.D.,
Presentation transcript:

Membrane type-1 matrix metalloproteinase is induced following cyclic compression of in vitro grown bovine chondrocytes  J.N.A. De Croos, Ph.D., B. Jang, B.Sc., S.S. Dhaliwal, B.Sc., M.D. Grynpas, Ph.D., R.M. Pilliar, Ph.D., R.A. Kandel, M.D.  Osteoarthritis and Cartilage  Volume 15, Issue 11, Pages 1301-1310 (November 2007) DOI: 10.1016/j.joca.2007.04.006 Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 1 Schematic of biphasic construct with agarose plug. Chondrocytes are seeded on the top surface of CPP cylinders surrounded by a Tygon tubing to prevent cell spillage during seeding. Chondrocytes attach and form a thin layer of tissue on top of the CPP by 3 days. An agarose plug is placed onto the construct immediately prior to application of cyclic compression. Osteoarthritis and Cartilage 2007 15, 1301-1310DOI: (10.1016/j.joca.2007.04.006) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 2 Cyclic compression increases Egr-1-dependent transcriptional activation of MT1-MMP. Isolated chondrocytes were transfected with MT1-MMP(−300)-luciferase pGL3 or mutant MT1-MMP-m1 (containing a GG to TA mutation within the Egr-1 binding site between −288 and −275) reporter constructs prior to seeding onto CPP substrates. After 3 days of incubation, samples were either cyclically compressed for 30min (1kPa, 1Hz) in serum-free media or left unstimulated. RLU was measured 24h later and normalized to expression of Renilla luciferase. * indicates a significant difference to unstimulated chondrocytes, P<0.05. Osteoarthritis and Cartilage 2007 15, 1301-1310DOI: (10.1016/j.joca.2007.04.006) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 3 MT1-MMP expression in cyclically compressed chondrocytes. Chondrocytes were cyclically compressed for 30min or left unstimulated (US) as a control. Total RNA or protein was harvested from samples during and after mechanical stimulation and semi-quantified by RT-PCR analysis or western blot, respectively. −15 indicates the time during mechanical stimulation when the samples were harvested (at 15min which is halfway through the period of cyclic compression). All other samples were harvested at various times after mechanical stimulation was completed ranging from immediately after (time 0) up to 24h later. (A) MT1-MMP gene expression which is expressed as a fold change compared to US controls. Gene expression was normalized to 18S rRNA. (B) Representative western blots showing MT1-MMP and β-actin protein expression in US and stimulated (S) cells over time. β-actin was used to ensure equal loading of proteins. (C) Fold change in MT1-MMP protein expression over time in the presence of stimulation as determined by densitometry. * indicates that the mechanically S sample is significantly different from the corresponding US control, P<0.05. Osteoarthritis and Cartilage 2007 15, 1301-1310DOI: (10.1016/j.joca.2007.04.006) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 4 DNA binding activity at the MT1-MMP promoter. EMSA of nuclear extracts obtained from unstimulated (US) and stimulated (S) chondrocytes at (A) various time points post-stimulation or (B) immediately (0min) after mechanical stimulation in the presence or absence of various inhibitors. The competitors were used at 10-fold excess (10×). EMSA were repeated at least three times. An overexposed EMSA is shown in (B) to demonstrate the supershift band. Osteoarthritis and Cartilage 2007 15, 1301-1310DOI: (10.1016/j.joca.2007.04.006) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 5 Egr-1 expression in cyclically compressed chondrocytes. Chondrocytes were cyclically compressed for 30min and total RNA or protein harvested. −15 indicates the time during mechanical stimulation when the samples were harvested (at 15min which is halfway through the period of cyclic compression). All other samples were harvested at various times after mechanical stimulation was completed ranging from immediately after (time 0) up to 24h later. Controls were treated identically but were not stimulated (S). (A) Egr-1 gene expression was normalized to 18S rRNA gene expression and then expressed as fold change relative to unstimulated (US) controls. (B) Representative western blots showing Egr-1 and β-actin protein levels in US and S cells over time. β-actin was used to ensure equal loading of proteins. (C) Fold change in Egr-1 protein expression over time in the presence of stimulation. Protein expression was semi-quantified using densitometry and the data pooled and expressed as mean±s.e.m. as described under the Methods section. * indicates that the mechanically S sample is significantly greater than the corresponding US control, P<0.05. ** indicates that the mechanically S samples are significantly lower than the corresponding US control, P<0.05. Osteoarthritis and Cartilage 2007 15, 1301-1310DOI: (10.1016/j.joca.2007.04.006) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 6 Inhibition of Egr-1 and the effect on MT1-MMP. (A) EMSA of DNA binding activity to an MT1-MMP promoter sequence in nuclear proteins extracted from chondrocytes which had undergone cyclic compression in the presence of vehicle alone, phosphorothioated MT1-MMP ODN or phosphorothioated mutant MT1-MMP ODN. The proteins were obtained immediately after mechanical stimulation (at time 0). Control cells were treated similarly but did not undergo mechanical stimulation (US). (B) Total RNA was extracted 15min after mechanical stimulation ended. Relative RT-PCR analysis of MT1-MMP gene expression in cells treated with vehicle alone, phosphorothioated MT1-MMP ODN or phosphorothioated mutant MT1-MMP ODN. Gene expression was normalized to 18S rRNA and expressed as the fold change of stimulated (S) to unstimulated (US) samples. * indicates a significant difference between groups, P<0.05. Osteoarthritis and Cartilage 2007 15, 1301-1310DOI: (10.1016/j.joca.2007.04.006) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 7 ERK1/2 activation during cyclic compression of chondrocytes. (A) Chondrocytes were cyclically compressed and tissues were harvested after 5min (−25), 15min (−15) or 30min (0) of mechanical stimulation. Total proteins were extracted and examined by immunoblotting with antibodies reactive to total or phosphorylated ERK1/2 and semi-quantified by densitometry. Representative western blots showing phosphorylated ERK1/2 and total ERK1/2 levels in unstimulated (US) and stimulated (S) chondrocytes. (B) Fold change in phospho-ERK1/2 protein expression over time in the presence of stimulation. The results of four experiments were combined and the levels of p-ERK1/2 were expressed as mean±s.e.m. * indicates a significant difference from corresponding US control. (C) EMSA of DNA binding activity to an MT1-MMP promoter sequence using nuclear proteins from mechanically S chondrocytes treated with U0126 or vehicle alone and extracted immediately after cyclic compression. Control cells were treated similarly but did not undergo mechanical stimulation (US). (D) Total RNA was extracted 15min after mechanical stimulation ended. RT-PCR analysis of MT1-MMP gene expression in chondrocytes treated with U0126 or vehicle alone. Gene expression was normalized to 18S rRNA and expressed as the fold change of S to US samples. ** indicates a significant difference between groups, P<0.05. Osteoarthritis and Cartilage 2007 15, 1301-1310DOI: (10.1016/j.joca.2007.04.006) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions